RECENT NEWS

Roche has recently announced the completion of the acquisition of LumiraDx’s point-of-care technology, following the receipt of all required antitrust and regulatory clearances. Roche will now embark on the full integration of the company’s innovative multi-assay point of care platform and the related R&D, operational and commercial sites into its global organisation.

Scientists at the University of Warwick have made a breakthrough which could help find new treatments for a deadly infection that can affect up to 40% of hospital patients using mechanical ventilators.

New data from the UK Health Security Agency (UKHSA) highlights a rise in antibiotic-resistant gonorrhoea infections in England.

The latest issue of Pathology in Practice is now available to read online.

The Medical Research Council (MRC), in collaboration with the Biotechnology and Biological Sciences Research Council (BBSRC), has provided £28.5 million in funding to establish the Human Functional Genomics Initiative programme. It aims to advance our understanding of how genomic variation influences human physiology and how it changes over time and in disease.

Stago UK is introducing a unique autotransfusion system, able to preserve functional platelets as well as red blood cells. It offers a safer alternative to scarce, risky and expensive blood transfusion products. Stago UK has partnered with i-SEP, one of France’s most innovative MedTech companies, to distribute its novel ‘same’ system.

Paige, a global leader in clinical AI applications for cancer, in collaboration with Microsoft, has unveiled the second generation of Virchow, its million-slide foundation model for cancer.

Beckman Coulter Life Sciences, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, offers a promising new approach to oncology research delivering faster results with fewer touchpoints. The Illumina TruSight Oncology 500 DNA/RNA assay on the Biomek NGeniuS System from Beckman Coulter Life Sciences provides an automated solution enabling comprehensive genomic profiling of tumour samples.

MIP Discovery has announced the company’s rebrand to Tozaro, completing its transition to becoming a technology innovator in the cell and gene therapy (CGT) bioprocessing sector.

Fimlab Laboratories has selected Aiforia Technologies as the provider for breast and prostate cancer diagnostics solutions. Fimlab is Finland’s largest healthcare laboratory company, owned by the wellbeing services counties of Pirkanmaa, Central Finland, Kanta-Häme, Ostrobothnia, and Päijät-Häme.

Research published in the Journal of Parkinson's Disease shows promise for finding an objective, quantifiable, less-invasive biomarker for diagnosing Parkinson's disease.

National charity Group B Strep Support has produced a new free eLearning module on group B Streptococcus (GBS), to be used as a vital resource for midwives, doctors and health professionals in maternity services. It offers vital evidence-based education on GBS to enhance the care of pregnant women and people, and their babies, and ultimately will help save lives.

Do-it-yourself human papillomavirus (HPV) tests could allow an extra one million women in England to participate in cervical screening over the next three years.

Bio-Rad Laboratories has expanded its Pioneer Antibody Discovery Platform services with the addition of fast generation and screening of bispecific antibodies, based on the company’s proprietary SpyLock technology.

Thermo Fisher Scientific recently announced that it has been 510k cleared, following US Food and Drug Administration (FDA) requirements, to market its Optilite Freelite assays’ claim for the evaluation of monoclonal gammopathy of undetermined significance (MGUS).

Agilent Technologies has received US Food and Drug Administration (FDA) approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with synovial sarcoma who may be eligible for treatment with TECELRA (afamitresgene autoleucel, also known as afami-cel or ADP-A2M4), a MAGE-A4-directed engineered TCR T-cell therapy.

INTEGRA’s innovative MAG and HEATMAG modules are designed to overcome problems with repetitive magnetic bead clean-up by automating the movement of a magnet to capture magnetic beads, simplifying proteomics and molecular biology laboratory preparation protocols.

Torrey Pines Scientific has launched its EchoTherm Model IC50 Peltier driven Chilling/Heating Dry Bath with exact sample temperature control.

An independent review of the Care Quality Commission (CQC) has identified significant internal failings which is hampering its ability to identify poor performance at hospitals, care homes and GP practices.

Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.